Gene expression profiles differentiate between sterile SIRS and early sepsis

Annals of Surgery

Volumn 245, Issue 4, 2007, Pages 611-621

  Johnson, Steven B ^a   Lissauer, Matthew ^a   Bochicchio, Grant V ^a   Moore, Richard ^a   Cross, Alan S ^b   Scalea, Thomas M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BD Diagnostics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR;

ADULT; ARTICLE; BLOOD; CONTROLLED STUDY; CRITICALLY ILL PATIENT; FEMALE; GENE EXPRESSION; GENE PROBE; HUMAN; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; T LYMPHOCYTE; UNIVARIATE ANALYSIS;

ADULT; APOPTOSIS; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INTERLEUKINS; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEPSIS; SIGNAL TRANSDUCTION; STAT4 TRANSCRIPTION FACTOR; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UP-REGULATION;

EID: 34147192019     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000251619.10648.32     Document Type: Article

References (59)

1. Parrillo JE, Parker MM, Natanson C, et al. Septic shock in humans. Ann Int Med. 1990;113:227-242.
2. Sprung CL, Sakr Y, Vincent J-L, et al. An evaluation of systemic inflammatory response syndrome signs in the sepsis occurrence in acutely ill patients (SOAP) study. Intensive Care Med. 2006;32:421-427.
3. Papain JA, Hunter T, Palsson BO, et al. Reconstruction of cellular signaling networks and analysis of their properties. Nature Rev Mol Cell Biol. 2005;6:99-111.
4. Calvano SE, Xiao W, Richards DR, et al. A network based analysis of systemic inflammation in humans. Nature. 2005;437:1032-1037.
5. American College of Chest Physician/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864-874.
6. Bone RC, Sprung CL, Sibbald WJ. Definitions for sepsis and organ failure. Crit Care Med. 1992;20:724-726.
7. Levy MM, Fink MP, Marshall JC, et al. SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference: 2003. Crit Care Med. 2001;31:1250-1256.
8. www.preanalytix.com/RNA.asp
9. Feezor RJ, Baker HV, Mindrinos M, et al. Whole blood and leukocyte RNA isolation for gene expression analysis. Physiol Genomics. 2004;19:247-254.
10. Cobb JP, Mindronos MN, Miller-Graziano CL, et al. Application of genome-wide expression analysis to human health and disease. Proc Nat Acad Sci USA. 2005;102:4801-4806.
11. Application Note: "Blocking of Globin Reverse Transcription to Enhance Whole Blood Gene Expression Profiling" available at http://www.genelogic.com
12. Troyanskaya O, Cantor M, Sherlock G, et al. Missing value estimation methods for DNA microarrays. Bioinformatics. 2001;17:520-525.
13. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc B. 1995;57:289-300.
14. Tibshirani R, Hastie T, Narasimhan B, et al. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Nat Acad Sci USA. 2002;99:6567-6572.
15. Breiman L, Friedman J, Olshen R, et al. Classification and Regression Trees. New York: Chapman and Hall, 1984.
16. Friedman JH. Stochastic gradient boosting. Comput Stat Data Anal. 2002;38:367-378.
17. Breiman L. Random forests. Machine Learning. 2001;45:5-32.
18. Dennis G Jr, Sherman BT, Hosack DA, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Gen Bio. 2003;4:P3.
19. Hosack DA, Dennis G, Sherman BT, et al. Identifying biological themes within lists of genes with EASE. Gen Biol. 2003;4:P4.
20. Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000;28:27-30.
21. Kanehisa M, Goto S, Hattori M, et al. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res. 2006;34:D354-D357.
22. Biocarta Pathways available at http://www.biocarta.com/genes/index.asp.
23. International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature. 2001;409:860-921.
24. Wang ZM, Liu C, Dziarski R. Chemokines are the main proinflammatory mediators in human monocytes activated by Staphylococcal aureus, peptidogylcan, and endotoxin. J Biol Chem. 2000;275:20260-20267.
25. Feezor RJ, Oberholzer C, Baker HV, et al. Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria. Infect Immun. 2003;71:5803-5813.
26. Beutler B. Key inflammatory and stress pathways in critical illness: the central role of Toll-like receptors. Crit Care. 2003;7:39-46.
27. Hallman M, Ramet M, Ezekowitz RA. Toll-like receptors as sensors of pathogens. Pediatr Res. 2001 50:315-321.
28. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol. 2003;21:335-376.
29. Medzhitov R. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell. 1998;2:253-258.
30. Suzuki N, Suzuki S, Duncan GS, et al. Severe impairment of interleukin-1 and Toll-like receptor signaling in mice lacking IRAK-4. Nature. 2002;416:750-756.
31. Moynagh PN. TLR signaling and the activation of IRFs: revisiting old friends from the NF-κβ pathway. Trends Immunol. 2005;26:469-476.
32. Rudolph D, Yeh WC, Wakeham A, et al. Severe liver degeneration and lack of NF-κβ activation in NEMO/IKK deficient mice. Genes Dev. 2000;14:854-862.
33. Ono K, Han J. The p38 signal transduction pathway: activation and function. Cell Signal. 2000;12:1-13.
34. Maitra SR, Chen E, Rosa D, et al. Modulation of signal transduction pathways during sepsis and the effects of insulin and mifepristone. Acad Emerg Med. 2003;10:1-8.
35. Grotzinger J. Molecular mechanisms of cytokine receptor activation. Biochim Biophys Acta. 2002;1592:215-223.
36. LePoul E, Loison C, Struyf S, et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem. 2003;278:25481-25489.
37. Van der Poll T, Lowry SF. Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense? Shock. 1995;3:1-12.
38. Ulloa L, Tracey K. The cytokine profile: a code for sepsis. Trends Mol Med. 2005;11:56-63.
39. Pagenstecher A, Stalder AK, Kincaid CL, et al. Regulation of matrix metalloproteinases and their inhibitor genes in lipopolysaccharide-induced endotoxemia in mice. Am J Pathol. 2000;157:197-210.
40. Johnson SB, Bochicchio G, Shanholtz C, et al. Uninfected systemic inflammatory response syndrome (SIRS) or future sepsis? Differences in extracellular matrix modulators prior to onset of clinical sepsis. Chest. 2005;128(suppl):221.
41. Nagata T, Kai H, Shibata R, et al. Oncostatin M, an interleukin-6 family cytokine, upregulates matrix metalloproteinase-9 through the mitogen-activated protein kinase kinase-extracellular signal-regulated kinase pathway in cultured smooth muscle cells. Arterioscler Thromb Vasc Biol. 2003;23:588-593.
42. Martin MU, Wesche H. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Biochim Biophys Acta. 2002;1592:265-280.
43. Jo D, Liu D, Yao S, et al. Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis. Nat Med. 2005;11:892-898.
44. Rogge L, Barberis-Maino L, Biffl M, et al. Selective expression of an interleukin-12 receptor component by human helper 1 cells. J Exp Med. 1997;185:825-831.
45. Uddin S, Lekmine F, Sassano A, et al. Role of STAT5 in type I interferon signaling and transcriptional regulation. Biochem Biophys Res Commun. 2003;308:325-330.
46. Visconti R, Gadina M, Chiariell M. Importance of the MKK6/p38 pathway for IL-12 induced STAT4 serine phosphorylation and transcriptional activity. Blood. 2000;96:1844-1852.
47. Farrar JD, Asnagli, Murphy KM. T helper subset development: roles of instruction, selection, and transcription. J Clin Invest. 2002;109:431-435.
48. Power C, Fanning N, Redmond HP. Cellular apoptosis and organ injury in sepsis. Shock. 2002;19:197-211.
49. Siegel RM. Caspases at the crossroads of immune-cell life and death. Nat Immunol Rev. 2006;6:308-317.
50. Peter ME, Krammer PH. The CD95 (APO-1/FAS) DISC and beyond. Cell Death Differ. 2003;10:26-35.
51. Lee K-K, Ohyama T, Yajima N, et al. MST, a physiological caspase substrate, highly sensitizes apoptosis both upstream and downstream of caspase activation. J Biol Chem. 2001;276:19276-19285.
52. Tong T, Ji J, Jin S, et al. GADD45A expression induces Bim dissociation from the cytoskeleton and translocation to mitochondria. Mol Cell Biol. 2005;25:4488-4500.
53. Kam PCA, Ferch NI. Apoptosis: mechanisms and clinical implications. Anaesthesia. 2000;55:1081-1093.
54. Kucharczak JK, Simmons MJ, Fan Y, et al. To be, or not to be: NF-κβ is the answer - role of Rel/NF-κβ in the regulation of apoptosis. Oncogene. 2003;22:8961-8982.
55. Cobb JP, Hotchkiss RS, Karl IE, et al. Mechanisms of cell injury and death. Br J Anaesth. 1996;77:3-10.
56. Papa S, Zazzeroni F, Bubici C, et al. GADD45B mediates the NF-κβ suppression of JNK signaling by targeting MKK7/JNKK2. Nat Cell Biol. 2004;6:146-153.
57. Franke TF, Hornik CP, Segev L, et al. PI3K/Akt and apoptosis: size matters. Oncogene. 2003;22:8983-8998.
58. Toker A, Newton AC. Cellular signaling: pivoting around PDK-1. Cell. 2000;103:185-188.
59. Herbert TP, Kilhams GR, Batty IH, et al. Distinct signaling pathways mediate insulin and phorbol ester stimulated eukaryotic initiation factor 4F assembly and protein synthesis in HEK 293 cells. J Biol Chem. 2000;275:11249-11256.